Skip to main content
Equibles

CAPTRUST FINANCIAL ADVISORS

Position in TLRY — Tilray Brands, Inc.

CIK 1512024 RALEIGH, NC
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$102,942
-$67,167 QoQ
Shares Held
22,927
-12.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 235 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. TLRY ranks #22 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 121,151 $8,705,910
2 NBIX
Neurocrine Biosciences Inc
 45,360 $7,644,974
3 UTHR
UNITED THERAPEUTICS Corp
 9,855 $5,339,734
4 VTRS
Viatris Inc
 197,717 $3,139,745
5 HLN
Haleon plc
 263,202 $2,455,674
6 HROW
Harrow, Inc.
 56,414 $2,395,902
7 TAK
Takeda Pharmaceutical Co Ltd
 143,998 $2,308,287
8 ALKS
Alkermes plc.
 42,278 $2,215,367

All Filings in TLRY

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $102,942 22,927
2026-03-31 $170,109 26,292
2025-09-30 $284,361 164,371
2025-06-30 $46,995 114,622
2025-03-31 $80,379 121,787
2024-12-31 $154,047 115,825
2024-09-30 $32,076 18,225
2024-06-30 $34,069 20,524
2024-03-31 $178,605 72,310
2023-12-31 $153,706 66,829
2023-09-30 $51,088 22,375
2023-06-30 $27,800 17,821
2023-03-31 $30,494 12,053
2022-09-30 $29,680 10,793
2022-06-30 $30,182 9,674
2022-03-31 $62,626 8,060
2021-12-31 $58,117 8,267
2021-09-30 $88,592 7,847
2021-06-30 $113,976 6,304
2021-03-31 $58,734 2,584
2020-12-31 $18,221 2,206
2020-09-30 $1,484 306
2020-06-30 $6,271 882